Page last updated: 2024-09-03

candoxatril and Metabolic Syndrome

candoxatril has been researched along with Metabolic Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eizenberg, Y; Grossman, E; Peleg, E; Shabtai, Z; Sharabi, Y	1

Other Studies

1 other study(ies) available for candoxatril and Metabolic Syndrome

Article	Year
Neutral endopeptidase inhibitor versus angiotensin converting enzyme inhibitor in a rat model of the metabolic syndrome. Journal of the American Society of Hypertension : JASH, 2014, Volume: 8, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Disease Models, Animal; Enalapril; Indans; Insulin; Male; Metabolic Syndrome; Propionates; Rats; Rats, Sprague-Dawley; Triglycerides	2014

Article

Year

Neutral endopeptidase inhibitor versus angiotensin converting enzyme inhibitor in a rat model of the metabolic syndrome.

Journal of the American Society of Hypertension : JASH, 2014, Volume: 8, Issue:4

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Disease Models, Animal; Enalapril; Indans; Insulin; Male; Metabolic Syndrome; Propionates; Rats; Rats, Sprague-Dawley; Triglycerides

2014